Effects of growth regulation on conditionally-transformed alginate-entrapped insulin secreting cell lines in vitro

Biomaterials

Volumn 26, Issue 22, 2005, Pages 4633-4641

  Simpson, Nicholas E ^a   Khokhlova, Nata ^a   Oca Cossio, Jose A ^a   McFarlane, Scott S ^b   Simpson, Chiab P ^a   Constantinidis, Ioannis ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alginate; Bioartificial pancreas; Doxycycline; Insulinoma cells; Tetracycline

Indexed keywords

ARTIFICIAL ORGANS; BIOMATERIALS; CELL CULTURE; GENETIC ENGINEERING; GROWTH KINETICS; HISTOLOGY; INSULIN; METABOLISM;

BIOARTIFICIAL PANCREAS; CELL GROWTH; CELL PROLIFERATION; PHENOTYPIC SHIFTS;

CELLS;

ALGINIC ACID; BIOMATERIAL; GLUCOSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL PANCREAS; BIOARTIFICIAL ORGAN; CELL METABOLISM; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONCENTRATION PROCESS; CONTROLLED STUDY; CYTOCHEMISTRY; DRUG EXPOSURE; GROWTH REGULATION; HISTOCHEMISTRY; IN VITRO STUDY; INSULIN RELEASE; INSULINOMA; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; SECRETORY CELL;

ALGINATES; ANIMALS; ARTIFICIAL ORGANS; CELL DIVISION; CELL LINE, TUMOR; DOXORUBICIN; GLUCOSE; GLUCURONIC ACID; HEXURONIC ACIDS; INSULIN; INSULINOMA; MICE; PANCREAS;

MURINAE;

EID: 13944256984     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.11.054     Document Type: Article

References (23)

1. F. Lim, and A.M. Sun Microencapsulated islets as bioartificial endocrine pancreas Science 210 1980 908 910
2. G. Reach Bioartificial pancreas Diabetic Med 10 1993 105 109
3. A.M. Sun, W. Parisius, H. Macmorine, M.V. Sefton, and R. Stone An artificial pancreas containing cultured islets of Langerhans Artif Organs 4 1980 275 278
4. J.P. Benson, K.K. Papas, I. Constantinidis, and A. Sambanis Towards the development of a bioartificial pancreas effects of poly-L-lysine on alginate beads with βTC3 cells Cell Transplant 6 1997 395 402
5. R. van Schilfgaarde, and P. de Vos Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets J Mol Med 77 1999 199 205
6. O. Smidsrod, and G. Skjak-Braek Alginate as immobilization matrix for cells Trends Biotechnol 8 1990 71 78
7. A.M. Sun Microencapsulation of pancreatic islet cells a bioartificial endocrine pancreas Methods Enzymol 137 1988 575 580
8. P. Soon-Shiong, E. Feldman, R. Nelson, T. Heintz, Q. Yao, Z. Yao, T. Zheng, N. Merideth, G. Skjak-Braek, R. Espevik, O. Smidsrod, and P. Sandford Long-term reversal of diabetes by the injection of immunoprotected islets Proc Natl Acad Sci USA 90 1993 5843 5847
9. P. de Vos, A.F. Hammel, and K. Tatarkiewicz Considerations for transplantation of encapsulated pancreatic islets Diabetologia 45 2002 159 173
10. N. Trivedi, M. Keegan, G.M. Steil, J. Hollister-Lock, W.M. Hasenkamp, C.K. Colton, S. Bonner-Weir, and G.C. Weir Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses Transplantation 71 2001 211 302
11. C.J. Weber, J. Kapp, M.K. Hagler, S. Safley, J.T. Chryssochoos, and E. Chaikof Long term survival of poly-L-lysine alginate microencapsulated islet xenografts in spontaneous diabetic NOD mice W.M. Kuhtreiber R.P. Lanza W.L. Chick Cell encapsulation technology and therapeutics 1999 Birkhauser Boston, MA 117 137
12. S. Efrat, M. Leiser, M. Surana, M. Tal, D. Fusco-Damane, and N. Fleischer Murine insulinoma cell line with normal glucose regulated insulin secretion Diabetes 42 1993 901 907
13. C.B. Newgard Cellular engineering and gene therapy strategies for insulin replacement in diabetes Diabetes 43 1994 341 350
14. K.K. Papas, R.C. Long Jr, I. Constantinidis, and A. Sambanis Development of a bioartificial pancreas I. Long-term propagation and basal and induced secretion from entrapped βTC3 cell cultures Biotechnol Bioeng 66 1999 219 230
15. N. Fleischer, C. Chen, M. Surana, M. Leiser, L. Rossetti, W. Pralong, and S. Efrat Functional analysis of a conditionally transformed pancreatic β-cell line Diabetes 47 1998 1419 1425
16. D. Milo-Landesman, M. Surana, I. Berkovich, A. Compagni, G. Christofori, N. Fleischer, and S. Efrat Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic beta cells controlled by the tet-on regulatory system Cell Transplant 10 2001 645 650
17. i on the mechanism of insulin secretion in the mouse insulinoma βTC3 cell line Biochem J 326 1997 807 814
18. C. Stabler, K. Wilks, A. Sambanis, and I. Constantinidis The effects of alginate composition on encapsulated βTC3 cells Biomaterials 22 2001 1301 1310
19. I. Constantinidis, I. Rask, R.C. Long Jr, and A. Sambanis Effects of alginate composition on the metabolic, secretory, and growth characteristics of entrapped βTC3 mouse insulinoma cells Biomaterials 20 1999 2019 2027
20. R. Coger, M. Toner, P. Moghe, R. Ezzell, and M.L. Yarmush Hepatocyte aggregation and reorganization of EHS matrix gel Tissue Eng 3 1997 375 390
21. 2-guluronic acid interaction on alginate encapsulated βTC3 cells Biomaterials 25 2004 2603 2610
22. Y. Zimmer, D. Milo-Landesman, A. Svetlanov, and S. Efrat Genes induced by growth arrest in a pancreatic β cell line identification by analysis of cDNA arrays FEBS Lett 457 1999 65 70
23. Cheng S-Y, Constantinidis I, Sambanis A. Dynamics of insulin secretion by alginate-encapsulated insulin secreting cells. Cell Transplant, 2004, submitted for review.